Expo News Today — September 25, 2026

The financial world is abuzz with major developments that highlight the complexities of global business and personal finance. In a stunning turn of events, a pharma stock skyrocketed 150% after announcing a deal with Novo, the maker of Wegovy, a popular weight-loss medication. This significant surge underscores the market's enthusiasm for innovative pharmaceutical solutions and strategic partnerships.

Meanwhile, concerns about transparency and regulatory compliance are coming to the fore. A Virginia tech firm's CEO, a Russian national, has been charged with concealing the company's ties to Russia from the US government, emphasizing the importance of disclosure and due diligence in business dealings. On a different note, market trends and investment strategies are also making headlines, with some questioning the conventional wisdom of buying and holding stocks for the long term. Additionally, families are being advised to apply for college aid now that the FAFSA has opened early, and individuals are grappling with complex personal finance decisions, such as caring for aging parents and navigating family dynamics. These stories collectively illustrate the multifaceted nature of finance and markets, where business, policy, and personal finance intersect.

Today's signal:
• Pharma stock soars 150% on injectables deal with Wegovy maker Novo (cnbc.com)
• Virginia tech firm's CEO, Russian national charged with hiding firm's Russian ties from U.S. government (cnbc.com)
• Here's who is attending the Trump-Xi state dinner (cnbc.com)
• The case against buying and holding stocks for the long term (marketwatch.com)
• FAFSA opens early: Why families should apply for college aid now (cnbc.com)
• I spend my time and money caring for my aging mother — yet she gave my brother $100,000. Should I pull back? (marketwatch.com)